{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:00:28Z","timestamp":1791536428930,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.nmd.2026.106389","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:56:33Z","timestamp":1772207793000},"page":"106389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Overview of facioscapulohumeral dystrophy clinical features and diagnostic pathway"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5909-4783","authenticated-orcid":false,"given":"Brianna N.","family":"Brun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Camarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-4257","authenticated-orcid":false,"given":"Nick","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Statland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2026.106389_bib0001","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106389_bib0002","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.nmd.2026.106389_bib0003","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/brain\/awab326","article-title":"Predictors of functional outcomes in patients with facioscapulohumeral muscular dystrophy","volume":"144","author":"Katz","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2026.106389_bib0004","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mus.23949","article-title":"Risk of functional impairment in Facioscapulohumeral muscular dystrophy","volume":"49","author":"Statland","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106389_bib0005","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ana.410390610","article-title":"Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY group","volume":"39","author":"Tawil","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0006","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013695","article-title":"Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7","volume":"13","author":"Banerji","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.nmd.2026.106389_bib0007","unstructured":"Padberg GWAM, Facioscapulohumeral disease. 1982, Faculty of Medicine (LUMC), Leiden University. p. 247."},{"key":"10.1016\/j.nmd.2026.106389_bib0008","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1080\/09638288.2023.2259310","article-title":"Psychosocial functioning in patients with altered facial expression: a scoping review in five neurological diseases","volume":"46","author":"Rasing","year":"2024","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.nmd.2026.106389_bib0009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/practneurol-2015-001353","article-title":"What's in a name? The clinical features of facioscapulohumeral muscular dystrophy","volume":"16","author":"Mul","year":"2016","journal-title":"Pr Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/mus.10108","article-title":"Poly-hill sign in facioscapulohumeral dystrophy","volume":"25","author":"Pradhan","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106389_bib0011","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.nmd.2014.05.012","article-title":"Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement","volume":"24","author":"Rijken","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106389_bib0012","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.clinbiomech.2014.07.008","article-title":"Trunk muscle involvement is most critical for the loss of balance control in patients with facioscapulohumeral muscular dystrophy","volume":"29","author":"Rijken","year":"2014","journal-title":"Clin Biomech (Bristol)"},{"key":"10.1016\/j.nmd.2026.106389_bib0013","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00415-010-5858-z","article-title":"Camptocormia phenotype of FSHD: a clinical and MRI study on six patients","volume":"258","author":"Jordan","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70332","article-title":"Camptocormia as a phenotypic variant of FSHD in the elderly: clinical, genetic, and imaging features","volume":"32","author":"Torchia","year":"2025","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0015","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/dmcn.14142","article-title":"Clinical features of facioscapulohumeral muscular dystrophy 1 in childhood","volume":"61","author":"Steel","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0016","unstructured":"Neyaz T, Conway KM, Yang Y, Butterfield RJ, Venkatesh S, Romitti PA, et al. Facioscapulohumeral muscular dystrophy diagnosed in childhood: a muscular dystrophy surveillance, tracking and research network cohort. Neuromuscul Disord [in press]."},{"key":"10.1016\/j.nmd.2026.106389_bib0017","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/mus.70007","article-title":"Hearing loss, retinal abnormality, and seizures in people with facioscapulohumeral muscular dystrophy","volume":"72","author":"Kilburn","year":"2025","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106389_bib0018","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.0b013e3182897116","article-title":"Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size","volume":"80","author":"Statland","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106389_bib0019","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mus.26717","article-title":"Respiratory muscle weakness in facioscapulohumeral muscular dystrophy","volume":"60","author":"Henke","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106389_bib0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mus.24218","article-title":"Restrictive lung involvement in facioscapulohumeral muscular dystrophy","volume":"50","author":"Scully","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106389_bib0021","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/mus.28031","article-title":"A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD)","volume":"69","author":"Varma","year":"2024","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106389_bib0022","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jns.2009.05.014","article-title":"Sleep disordered breathing in facioscapulohumeral muscular dystrophy","volume":"285","author":"Della Marca","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2026.106389_bib0023","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11325-019-01843-1","article-title":"Sleep-related breathing disorders in facioscapulohumeral dystrophy","volume":"23","author":"Runte","year":"2019","journal-title":"Sleep Breath"},{"key":"10.1016\/j.nmd.2026.106389_bib0024","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1573403X16666200708111553","article-title":"Right bundle branch block: current considerations","volume":"17","author":"Ikeda","year":"2021","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.nmd.2026.106389_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.668180","article-title":"Cardiac involvement in facioscapulohumeral muscular dystrophy (FSHD)","volume":"12","author":"Ducharme-Smith","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0026","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1590\/1980-57642021dn15-040015","article-title":"Cognitive profile of patients with facioscapulohumeral muscular dystrophy","volume":"15","author":"Dos Santos","year":"2021","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.nmd.2026.106389_bib0027","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S2468-2667(24)00302-5","article-title":"Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"10","author":"Collaborators","year":"2025","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.nmd.2026.106389_bib0028","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.nmd.2023.10.020","article-title":"The Dutch registry for facioscapulohumeral muscular dystrophy: cohort profile and longitudinal patient reported outcomes","volume":"33","author":"Kools","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106389_bib0029","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3233\/JND-240068","article-title":"Nociceptive pain in patients with neuromuscular disorders: a cross-sectional clinical study","volume":"11","author":"Sagerer","year":"2024","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2026.106389_bib0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mus.27688","article-title":"Self-reported reduced sleep quality and excessive daytime sleepiness in facioscapulohumeral muscular dystrophy","volume":"66","author":"Hoffmann","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106389_bib0031","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/jnnp.2004.050005","article-title":"Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I","volume":"76","author":"Kalkman","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2026.106389_bib0032","doi-asserted-by":"crossref","first-page":"e1720","DOI":"10.1212\/WNL.0000000000008393","article-title":"Self-management program improves participation in patients with neuromuscular disease: a randomized controlled trial","volume":"93","author":"Veenhuizen","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106389_bib0033","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0000000000001008","article-title":"Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: an RCT","volume":"83","author":"Voet","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106389_bib0034","first-page":"1344","article-title":"Limb-girdle muscular dystrophies","volume":"31","author":"Liewluck","year":"2025","journal-title":"Contin (Minneap Minn)"},{"key":"10.1016\/j.nmd.2026.106389_bib0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/WCO.0000000000001298","article-title":"Late-onset myopathies","volume":"37","author":"Salort-Campana","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0036","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214291","article-title":"Expert consensus on genetic diagnostic approaches for patients with limb-girdle muscular dystrophy","volume":"105","author":"Straub","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106389_bib0037","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41582-025-01139-x","article-title":"Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives","volume":"21","author":"Rahm","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0038","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/22143602251319164","article-title":"Recent progress in oculopharyngodistal myopathy research from clinical and genetic viewpoints","volume":"12","author":"Ishiura","year":"2025","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2026.106389_bib0039","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/WCO.0000000000001397","article-title":"Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy","volume":"38","author":"Inoue","year":"2025","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0040","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(25)00233-9","article-title":"Advances in the classification and management of idiopathic inflammatory myopathies","volume":"24","author":"Raaphorst","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101620","article-title":"Charting the phenotypic landscape of mitochondrial diseases through a systematic evaluation of pathogenic mitochondrial DNA and nuclear gene variants","volume":"28","author":"Ratnaike","year":"2026","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2026.106389_bib0042","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(24)00518-0","article-title":"Clinical insights in enzyme replacement therapy for metabolic storage disorders: lessons from Pompe disease","volume":"24","author":"van der Beek","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0043","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/B978-0-444-64076-5.00035-1","article-title":"Facioscapulohumeral muscular dystrophy","volume":"148","author":"Tawil","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0044","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cge.14533","article-title":"Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: update of the 2012 guidelines","volume":"106","author":"Giardina","year":"2024","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2026.106389_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/biom13111567","article-title":"Optical genome mapping for the molecular diagnosis of facioscapulohumeral muscular dystrophy: advancement and challenges","volume":"13","author":"Efthymiou","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.nmd.2026.106389_bib0046","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jmedgenet-2018-105949","article-title":"Deciphering the complexity of the 4q and 10q subtelomeres by molecular combing in healthy individuals and patients with facioscapulohumeral dystrophy","volume":"56","author":"Nguyen","year":"2019","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2026.106389_bib0047","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41431-024-01577-z","article-title":"The first genetically confirmed cohort of facioscapulohumeral muscular dystrophy from Northern India","volume":"32","author":"Vishnu","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2026.106389_bib0048","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2010.01.035","article-title":"Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution","volume":"86","author":"Lemmers","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2026.106389_bib0049","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cge.14031","article-title":"Facioscapulohumeral muscular dystrophy-reproductive counseling, pregnancy, and delivery in a complex multigenetic disease","volume":"101","author":"Vincenten","year":"2022","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2026.106389_bib0050","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/hmg\/ddae007","article-title":"Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression","volume":"33","author":"Wong","year":"2024","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2026.106389_bib0051","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddaf183","article-title":"Identification of KHDC1L, a DUX4-regulated protein, as a novel plasma biomarker in facioscapulohumeral muscular dystrophy","volume":"35","author":"Sutliff","year":"2026","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2026.106389_bib0052","article-title":"DUX4 signalling in the pathogenesis of facioscapulohumeral muscular dystrophy","volume":"21","author":"Lim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2026.106389_bib0053","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3233\/JND-221636","article-title":"A targeted approach for evaluating DUX4-regulated proteins as potential serum biomarkers for facioscapulohumeral muscular dystrophy using immunoassay proteomics","volume":"10","author":"Campbell","year":"2023","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2026.106389_bib0054","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/hmg\/ddy364","article-title":"MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD","volume":"28","author":"Wang","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2026.106389_bib0055","doi-asserted-by":"crossref","first-page":"e877","DOI":"10.1212\/WNL.0000000000200757","article-title":"Quantitative muscle analysis in FSHD using whole-body fat-referenced MRI: composite scores for longitudinal and cross-sectional analysis","volume":"99","author":"Mellion","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106389_bib0056","article-title":"Multi-scale machine learning model predicts muscle and functional disease progression in FSHD","author":"Blemker","year":"2025","journal-title":"BioRxiv"},{"key":"10.1016\/j.nmd.2026.106389_bib0057","doi-asserted-by":"crossref","first-page":"e1488","DOI":"10.1212\/WNL.0000000000009211","article-title":"Muscle ultrasound is a responsive biomarker in facioscapulohumeral dystrophy","volume":"94","author":"Goselink","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106389_bib0058","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41582-022-00762-2","article-title":"Facioscapulohumeral muscular dystrophy: the road to targeted therapies","volume":"19","author":"Tihaya","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0059","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1007\/s00415-024-12538-3","article-title":"French national protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD)","volume":"271","author":"Attarian","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","volume":"85","author":"Tawil","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.106389_bib0061","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/mus.25991","article-title":"Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy","volume":"57","author":"Moris","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106389_bib0062","doi-asserted-by":"crossref","DOI":"10.1177\/22143602251399244","article-title":"A toolkit for new facioscapulohumeral muscular dystrophy trial sites","author":"Kools","year":"2025","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2026.106389_bib0063","first-page":"1329","article-title":"Facioscapulohumeral muscular dystrophy","volume":"31","author":"Knox","year":"2025","journal-title":"Contin (Minneap Minn)"},{"key":"10.1016\/j.nmd.2026.106389_bib0064","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.28293","article-title":"A 5-year natural history cohort of patients with facioscapulohumeral muscular dystrophy determining disease progression and feasibility of clinical outcome assessments for clinical trials","volume":"71","author":"Kools","year":"2025","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2026.106389_bib0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nmd.2023.04.005","article-title":"268th ENMC workshop - genetic diagnosis, clinical classification, outcome measures, and biomarkers in facioscapulohumeral muscular dystrophy (FSHD): relevance for clinical trials","volume":"33","author":"Montagnese","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106389_bib0066","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12883-019-1452-x","article-title":"Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study","volume":"19","author":"LoRusso","year":"2019","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nmd.2026.106389_bib0067","doi-asserted-by":"crossref","first-page":"788.e1","DOI":"10.1016\/j.jpurol.2022.05.004","article-title":"Feasibility of establishing a multi-center research database using the electronic health record: the PURSUIT network","volume":"18","author":"Vemulakonda","year":"2022","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.nmd.2026.106389_bib0068","first-page":"87","article-title":"Impact of implementing structured note templates on data capture for hernia surgery","volume":"52","author":"Vetter","year":"2023","journal-title":"Health Inf Manag"},{"key":"10.1016\/j.nmd.2026.106389_bib0069","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JND-230171","article-title":"Facioscapulohumeral muscular dystrophy european patient survey: assessing patient reported disease burden and preferences in clinical trial participation","volume":"11","author":"McNiff","year":"2024","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2026.106389_bib0070","series-title":"225th ENMC International Workshop:: A Global FSHD Registry Framework","first-page":"782","volume":"27","author":"Mul","year":"2016"},{"key":"10.1016\/j.nmd.2026.106389_bib0071","unstructured":"Treat-NMD FSHD dataset. 2025 [cited Nov 2025]; Available from: https:\/\/www.treat-nmd.org\/what-we-do\/core-datasets\/fshd\/."},{"key":"10.1016\/j.nmd.2026.106389_bib0072","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/22143602241313117","article-title":"The participants' perspective on facioscapulohumeral muscular dystrophy trials in The Netherlands - a qualitative study","volume":"12","author":"Stinissen","year":"2025","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2026.106389_bib0073","unstructured":"Project Mercury - the global initiative to speed the delivery of therapies for FSHD. 2025 [cited Nov 2025]; Available from: https:\/\/projectmercuryfshd.org\/."},{"key":"10.1016\/j.nmd.2026.106389_bib0074","series-title":"279th ENMC International Workshop: Classification, Clinical Care, Outcome Measures and Biomarkers in Childhood Onset Facioscapulohumeral Dystrophy: Towards Standardizing Clinical Care and Ensuring Clinical Trial Readiness","volume":"55","author":"Dijkstra","year":"2024"},{"key":"10.1016\/j.nmd.2026.106389_bib0075","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-022-00100-2","article-title":"Designing clinical trials for rare diseases: unique challenges and opportunities","volume":"2","author":"Pizzamiglio","year":"2022","journal-title":"Nat Rev Methods Primers"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662600057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662600057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:57:49Z","timestamp":1774497469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089662600057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":75,"alternative-id":["S096089662600057X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106389","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of facioscapulohumeral dystrophy clinical features and diagnostic pathway","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106389"}}